[Lamotrigine in treatment of women with epilepsy].

Abstract

The paper presents the review of literature on the age aspect of using lamotrigine in pubertal period, in women of reproductive age, during pregnancy and lactation and in climacteric period. Special attention is drawn to the low teratogenic potential of this drug used as a monotherapy. It has been concluded that lamotrigine is expedient to be used in treatment of partial and generalized epilepsy in women.

• Authors: P N Vlasov, D V Dranko, O V Agranovich
• Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 111 Issue 5 Pt 2 Pg. 38-42 ( 2011) ISSN: 1997-7298 [Print] Russia (Federation)
• PMID: 23120788 (Publication Type: Journal Article, Review)

Chemical References

• Anticonvulsants
• Contraceptive Agents, Female
• Triazines
• Lamotrigine

Topics

• Abnormalities, Drug-Induced (etiology)
• Age Factors
• Anticonvulsants (adverse effects, pharmacokinetics, therapeutic use)
• Breast Feeding
• Contraceptive Agents, Female (administration & dosage)
• Contraindications
• Epilepsy (complications, drug therapy)
• Female
• Humans
• Lamotrigine
• Menopause (drug effects)
• Milk, Human (chemistry, metabolism)
• Placenta (metabolism)
• Pregnancy
• Pregnancy Complications (drug therapy)
• Triazines (adverse effects, pharmacokinetics, therapeutic use)